One approach to selectively restore cholinergic function in the brain and enhance cognitive function is direct activation of the neuronal muscarinic M1 receptor (M1R), as several lines of evidence have demonstrated that M1R is highly expressed in the brain regions associated with cognition, and its activators are expected to improve cognitive deficits in AD [4–9]. This evidence concerns the gene CHRM1 and Alzheimer disease.